13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and Activating Caspase-3. The gene discussed is CASP3; the disease is T-cell non-Hodgkin lymphoma.